ISRCTN41319771已完成不适用
Pilot project on the use of HPV DNA testing as primary screening test for cervical cancer precursors: A multicentre randomised controlled trial
CPO Piemonte (Italy)0 个研究点目标入组 130,000 人开始时间: 2010年3月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 130,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •Women aged 35 to 64 years resident in the relevant areas.
排除标准
- •1. Women previously enrolled in the NTCC trial (ISRCTN81678807)
- •2. Women unable to provide informed consent
研究者
相似试验
已完成
不适用
Human Papillomavirus (HPV) testing on self-collected samples to increase uptake of cervical screening in non-attendersISRCTN35286331Queen Mary University of London (UK)200
Unknown
不适用
Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in UrineCervical CancerNCT06261892WomenX Biotech Limited300
招募中
不适用
Prospective study on the efficacy of HPV testing for cervical screening in Japan: JCHO multicenter studyCervical cancerJPRN-UMIN000036190The Japan Community Health Care Organisation (JCHO)20,000
招募中
不适用
Screening of cervical precancers by HPV test among women in urban and rural community of MaharashtraCTRI/2019/12/022531Deapartment of Health Research
已完成
不适用
Compass Trial: A Randomised Controlled Trial of Primary Human Papillomavirus (HPV) Testing for Cervical Cancer Screening in Australia: Pilot StudyHuman Papillomavirus (HPV)Cancer - Cervical (cervix)Cervical cancerACTRN12613001207707Roche Molecular Systems Inc. and5,001